Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition.
Severson EA, Haberberger J, Hemmerich A, Huang RSP, Edgerly C, Schiavone K, Najafian A, Hiemenz M, Lechpammer M, Vergilio JA, Lesser G, Strowd R, Elvin J, Ross JS, Hegde P, Alexander B, Singer S, Ramkissoon S.
Severson EA, et al. Among authors: ross js.
Oncologist. 2023 Jan 18;28(1):e26-e35. doi: 10.1093/oncolo/oyac190.
Oncologist. 2023.
PMID: 36342081
Free PMC article.